Jilin Tianheng Pharmaceutical

Jilin Tianheng Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and sale of both Traditional Chinese Medicine (TCM) and chemical drugs. The company is particularly noted for its production of Lofexidine Hydrochloride, a non-opioid medication used to manage symptoms of opiate withdrawal. Its broader product portfolio includes treatments for cardiovascular, cerebrovascular, and musculoskeletal conditions, such as Compound Danshen Tablets and Glucosamine Hydrochloride. Headquartered in Jilin City, the company operates GMP-certified manufacturing facilities and maintains a strong presence in the domestic Chinese market. Jilin Tianheng was previously listed on the National Equities Exchange and Quotations (NEEQ) and continues to focus on integrating modern medical science with traditional herbal expertise.